BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9713831)

  • 1. TRH inactivation in the extracellular compartment: role of pyroglutamyl peptidase II.
    Charli JL; Vargas MA; Cisneros M; de Gortari P; Baeza MA; Jasso P; Bourdais J; Peréz L; Uribe RM; Joseph-Bravo P
    Neurobiology (Bp); 1998; 6(1):45-57. PubMed ID: 9713831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin release.
    Cruz R; Vargas MA; Uribe RM; Pascual I; Lazcano I; Yiotakis A; Matziari M; Joseph-Bravo P; Charli JL
    Peptides; 2008 Nov; 29(11):1953-64. PubMed ID: 18703099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum.
    Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL
    J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute administration of alcohol modulates pyroglutamyl amino peptidase II activity and mRNA levels in rat limbic regions.
    de Gortari P; Romero F; Cisneros M; Joseph-Bravo P
    Neurochem Int; 2005 Mar; 46(4):347-56. PubMed ID: 15707699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor up-regulates pyroglutamyl peptidase II activity in the rat hippocampus.
    Rodríguez-Molina V; Vargas MA; Joseph-Bravo P; Charli JL
    Neurosci Lett; 2009 Jan; 449(3):211-4. PubMed ID: 19013213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone regulates the diurnal variation of pyroglutamyl aminopeptidase II activity in the male rat adenohypophysis.
    Angel Vargas M; Uribe RM; Cisneros M; Romero F; González S; Joseph-Bravo P; Charli JL
    Eur J Endocrinol; 2002 Sep; 147(3):363-9. PubMed ID: 12213674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells.
    Vargas MA; Joseph-Bravo P; Charli JL
    Neuroendocrinology; 1994 Sep; 60(3):323-30. PubMed ID: 7969791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.
    Sánchez E; Vargas MA; Singru PS; Pascual I; Romero F; Fekete C; Charli JL; Lechan RM
    Endocrinology; 2009 May; 150(5):2283-91. PubMed ID: 19179432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic ethanol or glucose consumption alter TRH content and pyroglutamyl aminopeptidase II activity in rat limbic regions.
    de Gortari P; Cisneros M; Joseph-Bravo P
    Regul Pept; 2005 Apr; 127(1-3):141-50. PubMed ID: 15680480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting Enhances Pyroglutamyl Peptidase II Activity in Tanycytes of the Mediobasal Hypothalamus of Male Adult Rats.
    Lazcano I; Cabral A; Uribe RM; Jaimes-Hoy L; Perello M; Joseph-Bravo P; Sánchez-Jaramillo E; Charli JL
    Endocrinology; 2015 Jul; 156(7):2713-23. PubMed ID: 25942072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin-releasing hormone-induced down-regulation of pyroglutamyl aminopeptidase II activity involves L-type calcium channels and cam kinase activities in cultures of adenohypophyseal cells.
    Vargas MA; Cisneros M; Joseph-Bravo P; Charli JL
    J Neuroendocrinol; 2002 Mar; 14(3):184-93. PubMed ID: 11999717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid down regulation of pyroglutamyl peptidase II activity by arachidonic acid in primary cultures of adenohypophyseal cells.
    Baeza MA; Ponce G; Joseph-Bravo P; Charli JL
    Life Sci; 2001 Mar; 68(17):2051-60. PubMed ID: 11388706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amygdala kindling differentially regulates the expression of the elements involved in TRH transmission.
    de Gortari P; Uribe RM; García-Vázquez A; Aguilar-Valles A; Martínez A; Valdés A; Charli JL; Fernández-Guardiola A; Joseph-Bravo P
    Neurochem Int; 2006 Jan; 48(1):31-42. PubMed ID: 16213061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in TRH and its degrading enzyme pyroglutamyl peptidase II, during the development of amygdaloid kindling.
    de Gortari P; Fernández-Guardiola A; Martinez A; Cisneros M; Joseph-Bravo P
    Brain Res; 1995 May; 679(1):144-50. PubMed ID: 7648256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3-Me-His(2)]-TRH combined with dopamine withdrawal rapidly and transiently increases pyroglutamyl aminopeptidase II activity in primary cultures of adenohypophyseal cells.
    Bourdais J; Romero F; Uriostegui B; Cisneros M; Joseph-Bravo P; Charli JL
    Neuropeptides; 2000 Apr; 34(2):83-8. PubMed ID: 10985924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroxine-induced expression of pyroglutamyl peptidase II and inhibition of TSH release precedes suppression of TRH mRNA and requires type 2 deiodinase.
    Marsili A; Sanchez E; Singru P; Harney JW; Zavacki AM; Lechan RM; Larsen PR
    J Endocrinol; 2011 Oct; 211(1):73-8. PubMed ID: 21788297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices.
    Charli JL; Mendez M; Vargas MA; Cisneros M; Assai M; Joseph-Bravo P; Wilk S
    Neuropeptides; 1989 Oct; 14(3):191-6. PubMed ID: 2575716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: role of the cAMP pathway.
    Vargas MA; Bourdais J; Sanchez S; Uriostegui B; Moreno E; Joseph-Bravo P; Charli JL
    J Neuroendocrinol; 1998 Mar; 10(3):199-206. PubMed ID: 9576608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediobasal hypothalamic and adenohypophyseal TRH-degrading enzyme (PPII) is down-regulated by zinc deficiency.
    Alvarez-Salas E; Alcántara-Alonso V; Matamoros-Trejo G; Vargas MA; Morales-Mulia M; de Gortari P
    Int J Dev Neurosci; 2015 Nov; 46():115-24. PubMed ID: 26315400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated isoform of pyroglutamyl aminopeptidase II produced by exon extension has dominant-negative activity.
    Chávez-Gutiérrez L; Bourdais J; Aranda G; Vargas MA; Matta-Camacho E; Ducancel F; Segovia L; Joseph-Bravo P; Charli JL
    J Neurochem; 2005 Feb; 92(4):807-17. PubMed ID: 15686482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.